222 related articles for article (PubMed ID: 30010219)
21. Transcriptional silencing of fetal hemoglobin expression by NonO.
Li X; Chen M; Liu B; Lu P; Lv X; Zhao X; Cui S; Xu P; Nakamura Y; Kurita R; Chen B; Huang DCS; Liu DP; Liu M; Zhao Q
Nucleic Acids Res; 2021 Sep; 49(17):9711-9723. PubMed ID: 34379783
[TBL] [Abstract][Full Text] [Related]
22. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
[TBL] [Abstract][Full Text] [Related]
23. CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia.
Yang Y; Kang X; Hu S; Chen B; Xie Y; Song B; Zhang Q; Wu H; Ou Z; Xian Y; Fan Y; Li X; Lai L; Sun X
J Biol Chem; 2021; 296():100464. PubMed ID: 33639162
[TBL] [Abstract][Full Text] [Related]
24. Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies.
Wienert B; Martyn GE; Funnell APW; Quinlan KGR; Crossley M
Trends Genet; 2018 Dec; 34(12):927-940. PubMed ID: 30287096
[TBL] [Abstract][Full Text] [Related]
25. Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia.
Gemmo C; Breveglieri G; Marzaro G; Lampronti I; Cosenza LC; Gasparello J; Zuccato C; Fabbri E; Borgatti M; Chilin A; Finotti A; Gambari R
Anal Bioanal Chem; 2019 Nov; 411(29):7699-7707. PubMed ID: 31300855
[TBL] [Abstract][Full Text] [Related]
26. A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the γ-globin gene in β-thalassemia.
Gong Y; Zhang X; Zhang Q; Zhang Y; Ye Y; Yu W; Shao C; Yan T; Huang J; Zhong J; Wang L; Li Y; Wang L; Xu X
Blood; 2021 Mar; 137(12):1652-1657. PubMed ID: 33227819
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of γ-globin expression through Cas9 or base editor to treat β-hemoglobinopathies.
Wang L; Li L; Ma Y; Hu H; Li Q; Yang Y; Liu W; Yin S; Li W; Fu B; Kurita R; Nakamura Y; Liu M; Lai Y; Li D
Cell Res; 2020 Mar; 30(3):276-278. PubMed ID: 31911671
[No Abstract] [Full Text] [Related]
28. CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia.
Zeng S; Lei S; Qu C; Wang Y; Teng S; Huang P
Hum Genet; 2023 Dec; 142(12):1677-1703. PubMed ID: 37878144
[TBL] [Abstract][Full Text] [Related]
29. Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.
Pavani G; Fabiano A; Laurent M; Amor F; Cantelli E; Chalumeau A; Maule G; Tachtsidi A; Concordet JP; Cereseto A; Mavilio F; Ferrari G; Miccio A; Amendola M
Blood Adv; 2021 Mar; 5(5):1137-1153. PubMed ID: 33635334
[TBL] [Abstract][Full Text] [Related]
30. Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β
Cosenza LC; Zuccato C; Zurlo M; Gambari R; Finotti A
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292612
[TBL] [Abstract][Full Text] [Related]
31. Machine learning-based approaches for identifying human blood cells harboring CRISPR-mediated fetal chromatin domain ablations.
Li Y; Zaheri S; Nguyen K; Liu L; Hassanipour F; Pace BS; Bleris L
Sci Rep; 2022 Jan; 12(1):1481. PubMed ID: 35087158
[TBL] [Abstract][Full Text] [Related]
32. Plastrum testudinis induces γ-globin gene expression through epigenetic histone modifications within the γ-globin gene promoter via activation of the p38 MAPK signaling pathway.
Qian X; Chen J; Zhao D; Guo L; Qian X
Int J Mol Med; 2013 Jun; 31(6):1418-28. PubMed ID: 23588991
[TBL] [Abstract][Full Text] [Related]
33. CTD small phosphatase like 2 (CTDSPL2) can increase ε- and γ-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood.
Ma YN; Zhang X; Yu HC; Zhang JW
BMC Cell Biol; 2010 Oct; 11():75. PubMed ID: 20932329
[TBL] [Abstract][Full Text] [Related]
34. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.
Ye L; Wang J; Tan Y; Beyer AI; Xie F; Muench MO; Kan YW
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10661-5. PubMed ID: 27601644
[TBL] [Abstract][Full Text] [Related]
35. CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.
Gabr H; El Ghamrawy MK; Almaeen AH; Abdelhafiz AS; Hassan AOS; El Sissy MH
Stem Cell Res Ther; 2020 Sep; 11(1):390. PubMed ID: 32912325
[TBL] [Abstract][Full Text] [Related]
36. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.
Dever DP; Bak RO; Reinisch A; Camarena J; Washington G; Nicolas CE; Pavel-Dinu M; Saxena N; Wilkens AB; Mantri S; Uchida N; Hendel A; Narla A; Majeti R; Weinberg KI; Porteus MH
Nature; 2016 Nov; 539(7629):384-389. PubMed ID: 27820943
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.
Hariharan P; Sawant M; Gorivale M; Manchanda R; Colah R; Ghosh K; Nadkarni A
Mol Biol Rep; 2017 Oct; 44(5):413-417. PubMed ID: 28879539
[TBL] [Abstract][Full Text] [Related]
39. An Aγ-globin G->A gene polymorphism associated with β
Breveglieri G; Bianchi N; Cosenza LC; Gamberini MR; Chiavilli F; Zuccato C; Montagner G; Borgatti M; Lampronti I; Finotti A; Gambari R
BMC Med Genet; 2017 Aug; 18(1):93. PubMed ID: 28851297
[TBL] [Abstract][Full Text] [Related]
40. Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment.
Ali G; Tariq MA; Shahid K; Ahmad FJ; Akram J
Gene Ther; 2021 Feb; 28(1-2):6-15. PubMed ID: 32355226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
